Preimplantation Genetic Testing

Preimplantation Genetic Testing allows for the screening of embryos (preimplantation) before transfer to the uterus during IVF.

Early detection of genetic disorders and the transfer of healthy embryos reduces the risk of reproductive failure and birth of a child with a genetic defect.

Genetic testing can be divided into 2 types:

Preimplantation Genetic Screening (PGS) and Preimplantation Genetic Diagnosis (PGD).

Advantages

reduce the risk of having a baby with a genetic defect

increase the chance of having a healthy baby

identify the cause of recurrent miscarriages

increase the chance of successful in vitro

Take care of your health today

Preimplantation Genetic Testing (PGT) is a method which allows eliminating the risk of passing on genetic disorders to a child before the woman gets pregnant.

By examining the embryo cells, physicians are able to determine whether it has any DNA defects. For some patients, it is the only possibility of having healthy offspring.

PGD NGS method (preimplantation diagnosis based on next-generation sequencing platform) uses the most up-to-date techniques of human genome sequencing (reading of genetic information) for testing embryos and opens new diagnostic possibilities.

Thanks to preimplantation genetic testing it is possible to diagnose: Turner syndrome, Down, Edwards, Patau, Klinefelter, hemophilia, tuberous sclerosis, Huntington’s disease, cystic fibrosis, spinal muscular atrophy (SMA), Duchenne and Becker muscular dystrophy and other.

Early detection of defects and the transfer of healthy embryos reduces the risk of reproduction and birth failure of a child with a genetic defect.